ALTERITY THERAPEUTICS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0055 AUD | -8.33% |
|
-8.33% | -21.43% |
| 16/04 | ADRs End Lower, Purple Biotech Ltd. Declines 29% | DJ |
| 12/04 | ADRs End Lower, Leju Holdings Ltd. Declines 72% | DJ |
Chart calendar Alterity Therapeutics Limited
2aded047b621772a8b79ddb8f89f39c.PvgvsNbtyf7i9sNsvcdx48M92UobJMjcaG1rS4gDr8Q.aJsbwI7b-IuVoqgG2I4Crqd26gYsc_q7Dw46Kexq-YBOzVvdvbmTkJCapA~e9aab8efbc6ddba5c3570d4e222df153
Upcoming events on Alterity Therapeutics Limited
Past events on Alterity Therapeutics Limited
| 16/04/2024 11:15 pm | American Academy of Neurology Meeting |
| 16/04/2024 05:00 am | American Academy of Neurology Meeting |
| 14/04/2024 11:15 pm | American Academy of Neurology Meeting |
| 12/04/2024 | Extraordinary Shareholders Meeting |
| 28/02/2024 10:37 am | Q2 2024 Earnings Release |
| 02/02/2024 07:00 am | ShareCafe Hidden Gems Conference |
| 29/12/2023 04:30 am | Extraordinary Shareholders Meeting |
| 06/12/2023 03:30 am | Primates ATH434 Efficacy Data Results Call |
| 30/11/2023 | Future of Parkinson Disease Conference |
| 29/11/2023 03:30 am | Annual General Meeting |
| 30/10/2023 04:44 am | September 2023 Sales and Revenue Release - Activities Report |
| 28/08/2023 04:30 pm | Parkinson Disease and Movement Disorders International Congress - Abstract Number:181 |
| 28/08/2023 04:30 pm | Parkinson Disease and Movement Disorders International Congress - Abstract Number:162 |
| 22/06/2023 06:00 am | MST Access Rare Diseases Rich ReturnsForum |
| 22/05/2023 08:30 pm | Shareholder Access and Retail Engagement Conference - Fireside Chat |
| 27/04/2023 09:59 am | March 2023 Sales and Revenue Release - Activities Report |
| 10/03/2023 07:00 am | ShareCafe Hidden Gems Presentation |
| 28/02/2023 07:48 am | Q2 2023 Earnings Release |
| 31/01/2023 05:55 pm | December 2022 Sales and Revenue Release - Activities Report |
| 11/11/2022 | Annual General Meeting |
Annual results
| Fiscal Period | June | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 3,29 2,77 18.68% | 3,53 3,50 0.76% | 2,55 3,09 -17.31% | 1,87 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -10,8 -11,0 2.43% | -10,4 -10,9 4.49% | -9,32 -11,1 15.99% | -8,69 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -11,2 -11,9 5.69% | -8,79 -10,3 14.99% | -8,90 -11,0 19.32% | -8,84 |
|
Net income Million USD | Released Forecast Spread | -7,39 | -11,2 -11,9 5.69% | -8,84 -10,3 14.53% | -8,97 -11,0 18.71% | -8,84 |
|
EPS | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
| Announcement Date | 30/08/20 | 31/08/21 | 31/08/22 | 31/08/23 | - |
Quarterly results
| Fiscal Period | June | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,88 1,39 35.26% | 1,90 2,87 -33.69% | 1,62 1,82 -11.14% | 1,31 0,96 37.11% | 0,91 | |||
|
EBIT Million USD | Released Forecast Spread | -5,24 -5,61 6.7% | -5,19 -5,62 7.73% | -5,55 -5,10 -8.72% | -3,98 -5,65 29.53% | -4,17 -4,24 1.79% | -4,45 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -4,93 -5,73 13.95% | -4,26 -5,77 26.08% | -5,35 -5,21 -2.77% | -4,23 -4,32 2.06% | -4,52 | |||
|
Net income Million USD | Released Forecast Spread | -6,81 | -4,93 -5,73 13.95% | -4,78 | -4,31 -5,77 25.24% | -5,42 -5,21 -4.12% | -4,23 -4,32 2.06% | -4,52 | |
| Announcement Date | 25/02/21 | 31/08/21 | 28/02/22 | 31/08/22 | 28/02/23 | 31/08/23 | 29/02/24 | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Alterity Therapeutics Limited
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- ATH Stock
- Calendar Alterity Therapeutics Limited
